Literature DB >> 2362279

Synthesis and antiviral activity of metabolites of rimantadine.

P S Manchand1, R L Cerruti, J A Martin, C H Hill, J H Merrett, E Keech, R B Belshe, E V Connell, I S Sim.   

Abstract

The hydroxy metabolites of rimantadine (3-5) were synthesized and compared to amantadine (1) and rimantadine (2) for their ability to inhibit the replication of influenza viruses in vitro. All three metabolites were inhibitory to wild-type influenza A viruses (H3N2 and H1N1). In particular, 2-hydroxyrimantadine (3) showed similar activity to amantadine, but the 3- and 4-hydroxy metabolites (4 and 5, respectively), both of which are found in rimantadine-treated patients, showed only modest inhibitory activity. A rimantadine-resistant isolate of influenza A virus exhibited cross-resistance to amantadine and to each of the metabolites 3-5. None of the compounds were effective against influenza B virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2362279     DOI: 10.1021/jm00169a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Affinity of Rimantadine Enantiomers against Influenza A/M2 Protein Revisited.

Authors:  Antonios Drakopoulos; Christina Tzitzoglaki; Chulong Ma; Kathrin Freudenberger; Anja Hoffmann; Yanmei Hu; Günter Gauglitz; Michaela Schmidtke; Jun Wang; Antonios Kolocouris
Journal:  ACS Med Chem Lett       Date:  2017-01-27       Impact factor: 4.345

2.  Synthesis, antimicrobial and antiviral testing of some new 1-adamantyl analogues.

Authors:  Ghada S Hassan; Ali A El-Emam; Laila M Gad; Alaa Eldin M Barghash
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

3.  Catalyst-free multicomponent synthesis of novel adamantyl-containing tetrahydropyrimidine carboxylates.

Authors:  Utpalparna Kalita; Shunan Kaping; Jai Narain Vishwakarma
Journal:  Mol Divers       Date:  2016-01-21       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.